Recently, the Indian Council of Social Science Research, the highest body that funds and guides the social sciences in India, has initiated an in-house debate about the current state and the future prospects of such research. What is the quality of work that has come out of our universities and research institutes over the past 10-20 years? Which new areas of inquiry deserve more time, money and attention in the...

The proposed liberalisation of the mining and minerals sector is an assault on the rightful owners of the land and its resources. Tribal and indigenous communities across the world have been asserting their rights to the mineral wealth often found under the land they own or possess or have traditional rights to. They have been historically denied even a share of that huge wealth, leave alone legal rights of ownership. Under...

Veteran agricultural scientist and alumnus of Harvard and Berkeley Universities, Dr Peter Kenmore was in Mumbai for NABARD’s 30th anniversary lecture on ‘Future of Global Agriculture: Challenges and Opportunities for India.’ This United Nations Food & Agriculture Organization India representative spoke to Yogesh Pawar on the current scenario in agriculture. Some excerpts: There’s a lot of churn over GM technology in India. At a time when the country is grappling with...

Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous, multi-billion dollar anti-cancer drug Glivec, a development which challenges pharma MNCs' claims of cheap access and affordability for patented drugs. Such protests, which began first in Europe, and have now spread to the US, could make it more difficult for pharma MNCs in developing countries to convince sceptical governments...

There has been a six-fold increase in the number of antibiotics being popped by Indians. This includes the retail sale of Carbapenems -- powerful class IV antibiotics, typically used as a "last resort" to treat serious infections caused by multi-drug resistant, gram-negative pathogens. Research by the Centre for Disease Dynamics, Economics and Policy, Washington DC, has found that retail sale of carbapenems increased six times -- from 0.21 units per million...